Overview
The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution.
Eligibility
Inclusion Criteria:
- Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria
- 18 years or older
Exclusion Criteria:
- Chemotherapy before
- Other tumors